Atherosclerosis

Atherosclerosis is the buildup of lipid-rich plaque on arteries’ interior lining. While symptomless early on, it can lead to artery blockage and increased clot formation, which can cause a wide range of serious diseases, most commonly coronary heart disease and stroke. Lifestyle factors, such as poor diet, little exercise, and smoking, can be integral in the progression of atherosclerosis and its associated diseases.

Quick Answer

What it is

Atherosclerosis is the buildup of lipid-rich plaque on arteries’ interior lining. While symptomless early on, it can lead to artery blockage and increased clot formation, which can cause a wide range of serious diseases, most commonly coronary heart disease and stroke.

Key findings

  • Grade C: Atherosclerosis Risk (Naringenin)
  • Grade C: Vascular Calcification (Phosphorus)
  • Grade C: C-Reactive Protein (CRP) (Berberine)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Atherosclerosis

  • Supplements Studied:7
  • Research Trials:7
  • Total Participants:4,749
  • Top Supplement:Berberine (B)
7 trials
4,749 ppts
7 supps · 42 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

1426g daily

Reduces LDL oxidation and inhibits foam cell formation through AMPK activation

40 studies | 6,512 participants

Supporting Stack (Tier 2)

Inhibits DGAT2 enzyme reducing hepatic triglyceride synthesis and VLDL secretion

7 studies | 22,372 participants
See product label

Supports atherosclerosis through multiple complementary pathways

7 studies | 22,372 participants
179g daily

Modulates HMG-CoA reductase activity and increases LDL receptor expression

8 studies | 1,432 participants
2000mg daily

Supports atherosclerosis through multiple complementary pathways

10 studies | 180 participants

How It Works

This supplement protocol targets multiple biological pathways, which plays a central role in overall health and wellbeing. When this pathway functions optimally, the body maintains better atherosclerosis outcomes through improved cellular signaling and reduced physiological stress. This condition involves multiple interconnected physiological systems that can benefit from targeted nutritional support.

Berberine serves as the foundation of this protocol. It reduces LDL oxidation and inhibits foam cell formation through AMPK activation. Niacin (Vitamin B3) complements this approach by inhibits dgat2 enzyme reducing hepatic triglyceride synthesis and vldl secretion. niacin-vitamin-b3 complements this approach by supports atherosclerosis through multiple complementary pathways. Policosanol complements this approach by modulates hmg-coa reductase activity and increases ldl receptor expression.

Good clinical evidence supports this combination approach. By addressing multiple points along the multiple pathway, these supplements work synergistically to produce better results than any single intervention alone. The combined effect helps restore balance to systems that become dysregulated in atherosclerosis.

Rather than masking symptoms like conventional medications, these natural compounds support your body's intrinsic healing mechanisms and regulatory systems.

Initial improvements may be noticed within 4-6 weeks, with continued benefits developing over 2-3 months. Consistency is key. For best results, take with meals to enhance absorption unless otherwise directed and maintain regular daily use.

Generated from peer-reviewed researchSchema v

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
C
Atherosclerosis Risk
A review of literature (PMID 25483717) summarizes consistent preclinical evidence that naringenin reduces LDL and triglycerides, increases HDL, suppresses macrophage inflammation, and inhibits foam cell formation. In mice, naringin reduced atherosclerotic plaque by 41% over 18 weeks (PMID 21684135). One human RCT showed reduced arterial stiffness (PMID 26016866), supporting vascular benefit.
4 studies
moderateImproves
C
Vascular Calcification
Mechanistic and observational studies demonstrate that excess phosphorus promotes pathological vascular calcification by inducing osteogenic differentiation of vascular smooth muscle cells. Clinical studies in CKD patients show phosphate burden accelerates arterial calcification and vascular stiffness.
4 studies
moderateImproves
C
C-Reactive Protein (CRP)
Small Decrease
1 study
smallImproves
?
Total cholesterol
5 studies
Improves
?
Triglycerides
5 studies
Improves
?
High-density lipoprotein (HDL)
4 studies
Improves
?
Interleukin 6
2 studies
Improves
?
TNF-Alpha
2 studies
Improves
?
Low-density lipoprotein (LDL)
1 study
Improves
C
Apolipoprotein A
Small Increase
1 study
smallImproves
?
Apolipoprotein B
1 study
Improves
?
Heart Attack Risk
1 study
Worsens
?
High-density lipoprotein (HDL)
1 study
Improves
?
Low-density lipoprotein (LDL)
1 study
Improves
?
Stroke Risk
1 study
Worsens
?
Triglycerides
1 study
Improves
C
High-density lipoprotein (HDL)
Small Improvement
1 study
smallImproves
?
Low-density lipoprotein (LDL)
1 study
Improves
?
Total cholesterol
1 study
Improves
?
Triglycerides
1 study
Improves
C
High-density lipoprotein (HDL)
Small Improvement
1 study
smallImproves
?
Low-density lipoprotein (LDL)
1 study
Improves
?
Lymphocyte Count
1 study
Improves
?
Monocyte Count
1 study
Improves
?
Neutrophil Count
1 study
Improves
?
Serum Platelets
1 study
Improves
?
TMAO
1 study
Improves
?
Total cholesterol
1 study
Improves
?
Triglycerides
1 study
Improves
?
White Blood Cell Count
1 study
Improves
C
Microcirculation
Small Improvement
1 study
smallImproves
?
Oxidative Stress Biomarkers
1 study
Improves
D
Atherosclerosis Progression
In preclinical models, danshen compounds reduce oxidized LDL and inhibit smooth muscle cell hyperplasia after vascular injury (PMID:11367667). Magnesium lithospermate B protects human aortic endothelial cells from free radical damage in vitro (PMID:15250206). Human translation of these anti-atherogenic effects has not been established.
5 studies
smallWorsens
D
Endothelial Function
In apolipoprotein E-deficient mice, C3G supplementation protected against hypercholesterolemia-mediated endothelial dysfunction, attenuated atherosclerosis, and promoted endothelial repair in diabetic models. In vitro, C3G attenuated angiotensin II-induced oxidative stress in vascular endothelial cells and modulated miR-204-5p/SIRT1-mediated inflammation and apoptosis. No human cardiovascular trials with isolated C3G.
4 studies
moderateImproves
D
Atherosclerosis Progression
Network pharmacology and animal pharmacology studies on the Danshen-Shanzha herb pair suggest protective effects against atherosclerosis. A 2026 study demonstrated synergistic promotion of fatty acid oxidation via PPARα, Plin-5, and Plin-2 activation in metabolic liver disease models.
2 studies
smallWorsens
D
LDL Oxidation
In vitro studies show flavan-3-ols and procyanidins protect liposomes against lipid oxidation and bilayer disruption. Cocoa procyanidins protect LDL from oxidation regardless of polymer chain length when monomer units are controlled, suggesting monomeric flavanols are the active species.
2 studies
moderateImproves
D
Adiponectin
No effect
1 study
none
?
Blood glucose
1 study
Improves
?
C-Reactive Protein (CRP)
1 study
Improves
?
High-density lipoprotein (HDL)
1 study
Improves
?
Inflammation
1 study
Improves
?
Insulin
1 study
Worsens
?
LDL Oxidation
1 study
Improves
?
Low-density lipoprotein (LDL)
1 study
Improves
?
Total cholesterol
1 study
Improves
?
Triglycerides
1 study
Improves
D
Endogenous Advanced Glycation End Products
No effect
1 study
none
?
Pulse Wave Velocity
1 study
Improves
D
Atherosclerosis Progression
In a Wistar rat atherosclerosis model (high-lipid diet + vitamin D3), hederagenin improved blood rheology and endothelial function, corrected iNOS/eNOS imbalance, and inhibited IKKβ/NF-κB signaling with results comparable to atorvastatin at statistical significance (P < 0.01).
1 study
moderateImproves

Related Conditions

Cardiovascular Disease

8 shared supplements · 223 outcomes

Cardiovascular disease (CVD) is a broad term that refers to various diseases of the heart and blood vessels. Atherosclerotic CVD (ASCVD) is the most common subtype of CVD and causes strokes and heart attacks.

7 shared supplements · outcomes

Metabolic Health

6 shared supplements · 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

Cardiovascular Health

6 shared supplements · 31 outcomes

Research on heart health, blood vessel function, angiogenesis, and circulatory system.

Type 2 Diabetes

5 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

High Cholesterol

5 shared supplements · 553 outcomes

High amounts of low-density lipoproteins cause fatty plaques to build up in the arteries, which restricts blood flow and can cause health problems like a heart attack. Lifestyle factors (e.g., poor diet, smoking) and genetics play a huge role in blood cholesterol levels.

Dyslipidemia

5 shared supplements · 249 outcomes

Dyslipidemia is an imbalance in blood lipids in the body including cholesterol and triglycerides. Poor diet, tobacco use, and genetic factors can all contribute to dyslipidemia.

Bone Health

5 shared supplements · 82 outcomes

Bone health refers to the strength of bones and the quality of bone structure. Bone health is usually measured as bone mineral density. Bone health is affected by nutrient intake, hormonal regulation, exercise, and age, among other factors.